Ensign Group, Inc. (ENSG) director Mark Vincent Parkinson received a 600-share common-stock award on October 15, 2026; the shares vest in three equal annual installments beginning October 15, 2027. He sold 100 shares on October 16, 2026, at $179.62 per share under a Rule 10b5-1 trading plan adopted on November 6, 2025.
Ensign Group, Inc. director John O. Agwunobi was granted 600 shares of common stock on October 15, 2026. The shares vest in three equal annual installments beginning October 15, 2027. After the grant, he reported direct holdings of 10,103 shares. The transaction was reported at $0.00 per share.
Ensign Group, Inc. director Swati Bargotra Abbott was granted 600 shares of Common Stock on October 15, 2026. The shares vest in three equal annual installments beginning October 15, 2027. This is an award acquisition rather than a reported market purchase, and the reported transaction price was $0.00 per share.
Ann Scott Blouin, a director of Ensign Group, Inc. (ENSG), received a 600-share Common Stock award on October 15, 2026. The award was a direct acquisition, and her reported direct holdings after the transaction were 24,277 shares. The shares vest in three equal annual installments beginning October 15, 2027.
Ensign Group, Inc. director Daren Shaw acquired 600 common shares through an award on October 15, 2026, rather than a market purchase. The shares vest in three equal annual installments beginning October 15, 2027. His directly held position after the award was 25,526 shares.
Ensign Group, Inc. director Barry M. Smith received a grant of 600 shares of common stock on October 15, 2026, reported at $0.00 per share. His reported direct holdings after the grant were 22,552 shares.
Ensign Group, Inc. (ENSG) director Mark Parkinson is named in a notice reporting a proposed sale of 100 common shares, with an aggregate market value of $17,962 and an approximate sale date of October 16, 2026. Fidelity Brokerage Services LLC is listed as the broker. The shares are reported as compensation from restricted stock vesting from the issuer on October 15, 2026. The notice also reports a separate sale of 100 common shares on July 16, 2026, for gross proceeds of $16,812.
Ensign Group, Inc. (ENSG) director Marivic Uychiat Pison reported a bona fide gift of 580 shares of common stock on September 10, 2026. The transaction carried a reported per-share price of $0.00, consistent with a gift, and left the director holding 13,678 shares directly.
The Ensign Group, Inc. (ENSG) reported that its Board of Directors approved amended and restated bylaws effective August 20, 2026. The revisions align the bylaws with developments in Delaware law and clarify Board and meeting chair powers to regulate conduct at stockholder meetings.
The bylaws update procedural mechanics and disclosure requirements for stockholder director nominations and other business proposals, expanding the scope of information required about proposing stockholders, nominees and related persons. They also change the timing window for advance notice to generally 90 to 120 days before the anniversary of the prior annual meeting, with specific rules if a meeting is held more than 60 days after that anniversary.
Director candidates are now required to be available for interviews by Board members regarding their candidacy and qualifications. For the 2027 annual meeting, written notice of stockholder nominations or other business (outside Rule 14a-8) must be received between January 13, 2027 and February 12, 2027, while previously announced Rule 14a-8 and Rule 14a-19 deadlines remain unchanged.
The Ensign Group, Inc. (ENSG) entered into a Fourth Amended and Restated Credit Agreement on August 19, 2026, increasing its revolving credit facility by $200 million to an aggregate principal amount of $800 million and extending the maturity to August 19, 2031. Truist Bank acts as administrative agent for a lending syndicate that includes several major U.S. banks. Borrowings bear interest, at Ensign’s option, at either a base rate plus 0.25%–1.00% per year or Term SOFR plus 1.25%–2.00% per year, in each case tied to the ratio of Consolidated Total Net Debt to Consolidated EBITDA. Ensign will also pay a 0.175%–0.30% annual commitment fee on unused commitments and a drawn commitment fee of 1.25%–2.00% per year. Obligations are joint and several with Standard Bearer Healthcare REIT, Inc., guaranteed by certain domestic subsidiaries, and secured by liens on certain assets, with customary events of default.